ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum.
D000109:Acetylcholine / Q000502:physiology; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006168:Guinea Pigs; D007082:Ileum / Q000294:innervation*; D007150:Immunohistochemistry; D008297:Male; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D058919:Purinergic P2 Receptor Antagonists; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D018048:Receptors, Purinergic P2 / Q000502:physiology; D058472:Receptors, Purinergic P2Y1; D058831:Serotonin 5-HT3 Receptor Antagonists; D013368:Submucous Plexus / Q000502:physiology*; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D018733:Nicotinic Antagonists; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2; D058472:Receptors, Purinergic P2Y1; D058831:Serotonin 5-HT3 Receptor Antagonists; C077792:pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid; D014660:Vasoactive Intestinal Peptide; D011732:Pyridoxal Phosphate; D000255:Adenosine Triphosphate; D000109:Acetylcholine